Total Payments
$33,883
2024 Payments
$3,934
Companies
56
Transactions
1,740
Medicare Patients
5,743
Medicare Billing
$628,560
Payment Breakdown by Category
Food & Beverage$30,379 (89.7%)
Travel$2,583 (7.6%)
Education$907.05 (2.7%)
Consulting$14.29 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,379 | 1,692 | 89.7% |
| Travel and Lodging | $2,583 | 12 | 7.6% |
| Education | $907.05 | 35 | 2.7% |
| Consulting Fee | $14.29 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,448 | 200 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,837 | 288 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,316 | 126 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,814 | 86 | $0 (2024) |
| United Therapeutics Corporation | $1,742 | 87 | $0 (2024) |
| Medical Device Business Services, Inc. | $1,633 | 7 | $0 (2022) |
| GENZYME CORPORATION | $1,546 | 63 | $0 (2024) |
| Mylan Specialty L.P. | $1,425 | 74 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $1,329 | 83 | $0 (2024) |
| Genentech USA, Inc. | $1,327 | 83 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,934 | 172 | AstraZeneca Pharmaceuticals LP ($642.71) |
| 2023 | $5,789 | 270 | AstraZeneca Pharmaceuticals LP ($1,175) |
| 2022 | $6,499 | 262 | Medical Device Business Services, Inc. ($1,633) |
| 2021 | $3,951 | 214 | AstraZeneca Pharmaceuticals LP ($517.00) |
| 2020 | $2,011 | 129 | GlaxoSmithKline, LLC. ($446.68) |
| 2019 | $4,814 | 258 | Olympus Corporation of the Americas ($1,079) |
| 2018 | $3,361 | 219 | GlaxoSmithKline, LLC. ($705.70) |
| 2017 | $3,524 | 216 | GlaxoSmithKline, LLC. ($726.78) |
All Payment Transactions
1,740 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Immunology | ||||||
| 12/18/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/16/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardio-pulmonary | ||||||
| 12/11/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 12/10/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 12/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $102.82 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $35.70 | General |
| Category: Airway Clearance Device | ||||||
| 11/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,367 | 2,391 | $472,678 | $157,865 |
| 2022 | 17 | 1,326 | 2,309 | $496,944 | $162,180 |
| 2021 | 16 | 1,624 | 2,525 | $534,661 | $178,127 |
| 2020 | 18 | 1,426 | 2,272 | $435,730 | $130,387 |
Total Patients
5,743
Total Services
9,497
Medicare Billing
$628,560
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 390 | 806 | $209,560 | $77,851 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 627 | $107,844 | $38,661 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $43,600 | $13,452 | 30.9% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 36 | 37 | $32,671 | $6,885 | 21.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 59 | 167 | $15,865 | $6,580 | 41.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 53 | $17,278 | $5,274 | 30.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 33 | 33 | $7,920 | $2,157 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 38 | $6,688 | $2,047 | 30.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 161 | 162 | $6,642 | $1,487 | 22.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 156 | 157 | $4,239 | $1,073 | 25.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 121 | 123 | $6,073 | $959.55 | 15.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 11 | 11 | $6,886 | $704.41 | 10.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 12 | $5,844 | $372.42 | 6.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 55 | 56 | $1,568 | $361.76 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 381 | 808 | $210,080 | $77,408 | 36.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 641 | $110,462 | $36,182 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $34,000 | $10,627 | 31.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 61 | 63 | $20,538 | $6,515 | 31.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $20,408 | $6,225 | 30.5% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2022 | 31 | 31 | $27,373 | $5,874 | 21.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 63 | $16,642 | $5,121 | 30.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 26 | $16,666 | $4,488 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 49 | $8,624 | $3,117 | 36.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 136 | 137 | $5,617 | $1,305 | 23.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 22 | 35 | $3,325 | $1,055 | 31.7% |
About Dr. Nelson Greene, MD
Dr. Nelson Greene, MD is a Pulmonary Disease healthcare provider based in Salem, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801875455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelson Greene, MD has received a total of $33,883 in payments from pharmaceutical and medical device companies, with $3,934 received in 2024. These payments were reported across 1,740 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($30,379).
As a Medicare-enrolled provider, Greene has provided services to 5,743 Medicare beneficiaries, totaling 9,497 services with total Medicare billing of $628,560. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Salem, VA
- Active Since 01/12/2006
- Last Updated 11/28/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1801875455
Products in Payments
- DUPIXENT (Biological) $2,450
- ACTHAR (Biological) $1,870
- TRELEGY ELLIPTA (Drug) $1,436
- OFEV (Drug) $1,419
- NUCALA (Biological) $1,239
- FASENRA (Biological) $1,151
- UPTRAVI (Drug) $1,139
- Xolair (Biological) $973.46
- GLASSIA (Biological) $887.36
- TEZSPIRE (Biological) $852.71
- Yupelri (Drug) $829.11
- TYVASO (Drug) $824.04
- ORENITRAM (Drug) $777.24
- PURIFIED CORTROPHIN GEL (Drug) $726.55
- XOLAIR (Biological) $696.66
- Olympus Capital Accessories (Device) $673.35
- BREZTRI (Drug) $616.83
- FASENRA (Drug) $532.79
- LONHALA MAGNAIR (Drug) $521.40
- Prolastin-C Liquid (Biological) $500.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Salem
James Witten, Md, MD
Pulmonary Disease — Payments: $167,998
Pulmonary Disease $167,998
David Killeen, D.o, D.O
Pulmonary Disease — Payments: $132,565
Pulmonary Disease $132,565
Douglas Dorsey, M.d, M.D
Pulmonary Disease — Payments: $24,524
Pulmonary Disease $24,524
Matthew Cheng, Md, MD
Pulmonary Disease — Payments: $15,201
Pulmonary Disease $15,201
Steven Marvel, M.d, M.D
Pulmonary Disease — Payments: $11,509
Pulmonary Disease $11,509
Kamran Firoozi, M.d, M.D
Pulmonary Disease — Payments: $7,489
Pulmonary Disease $7,489